| Name | Title | Contact Details |
|---|---|---|
Michael Ruano |
Information Security Officer and Director | Profile |
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Roche Insulin Delivery Systems is a Fishers, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Patterson Companies, Inc (Patterson) is a value-added distributor serving three markets: North American dental supply, United States companion-pet (dogs, cats and other common household pets) and equine veterinary supply, and the worldwide rehabilitation
Information Television Network is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EnWave Corporation is a Prince George, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.